Hormonal Drugs Market

研究執行與發布：Coherent Market Insights　·　發布日期 2026-04-02　·　152 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

2026 年市場規模: USD 75 Bn
2033 年預估規模: USD 102 Bn
年複合成長率 CAGR: 4.49%

以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。

出版商 Coherent Market Insights 產業別 Healthcare & Life Sciences出版日期 2026-04-02頁數 152報告編號 CMI9414

授權報價

Single User Price	$4,500 USD
Enterprise License	$10,000 USD

洽詢購買申請 Sample

完整報告名稱與涵蓋範圍

Hormonal Drugs Market, By Product Type (Insulin and Analogues, Testosterone Therapies, Thyroid Hormone Therapies, Estrogen and Progesterone Therapies, Human Growth Hormone (HGH), Corticosteroids, Gonadotropins (FSH, LH, hCG), and Others), By Route of Administration (Oral, Parenteral/Injectable, Transdermal, Nasal, and Others), By Application (Endocrine Disorders, Reproductive Health, Oncology, Growth Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)

報告摘要

The global hormonal drugs market is estimated to be valued at USD 75 Bn in 2026 and is expected to reach USD 102 Bn by 2033, exhibiting a compound annual growth rate (CAGR) of 4.49% from 2026 to 2033. The global hormonal drugs market is an important segment of the overall pharmaceutical industry. These drugs are used to treat a wide range of conditions, including diabetes, thyroid disorders, reproductive health issues, growth hormone deficiencies, and hormone-related cancers. Key segments include insulin, thyroid hormones, sex hormones, corticosteroids, growth hormones, and hormone replacement therapies. The increasing incidence of lifestyle-related conditions and the growing geriatric population are increasing the demand for hormonal drugs. The market growth is further fueled by increasing healthcare awareness, development in drug delivery systems, and diagnostics. Acceptance of hormone replacement therapies, development of biosimilars, and personalized medicine is revolutionizing the way in which treatments are being carried out. Moreover, incorporation of digital technologies in monitoring and dose management is also contributing positively. Some of the major application segments that have been contributing significantly to the global hormonal drugs market include diabetes management, menopause therapy, fertility treatments, and pediatric growth disorders. Market Dynamics The hormonal drugs market is driven by the rising incidence rate of endocrine disorders like diabetes mellitus, which affects hundreds of millions worldwide and requires hormonal management in the form of insulin injections. The increase in life expectancy is also contributing to hormonal disorders like estrogen and testosterone deficiency, which is being managed through hormone replacement therapies. In addition, awareness about reproductive and fertility issues, as well as contraceptive practices, especially in developing nations with improving healthcare infrastructures, is also contributing to the growth of this market. At the same time, technological innovations in drug delivery systems are improving. Despite the presence of significant growth drivers, the market faces challenges such as regulatory requirements, which are becoming complex, leading to an increase in the cost of development. Long-term safety concerns, such as those of cardiovascular and cancer-related side effects, may also affect the use of hormonal drugs. Patent expiration of leading drugs in the market has led to an increase in generics, which in turn is affecting the pricing of the original drugs developed. However, the market for hormonal drugs presents an opportunity, which is in the form of biosimilars, which are both cost-effective and highly effective. The expansion of the use of hormonal therapies in cancer, such as hormone-sensitive tumors, is creating new revenue streams for the market. Additionally, the opportunity to include personalized medicine, such as genetic profiling, is creating new revenue streams for the market. Key Features of the Study • This report provides in-depth analysis of the global hormonal drugs market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2026–2033), considering 2025 as the base year • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players • It profiles key players in the global hormonal drugs market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies • Key companies covered as a part of this study include Pfizer Inc, Merck, Novartis AG, Hoffmann La Roche Ltd, Sanofi, Novo Nordisk A/S, Eli Lilly and Company, AbbVie Inc, Bayer AG, and Teva Pharmaceutical Industries Ltd • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics • The global hormonal drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global hormonal drugs market Market Segmentation • Product Type Insights (Revenue, USD Bn, 2021 - 2033) o Insulin and Analogues o Testosterone Therapies o Thyroid Hormone Therapies o Estrogen and Progesterone Therapies o Human Growth Hormone (HGH) o Corticosteroids o Gonadotropins (FSH, LH, hCG) o Others • Route of Administration Insights (Revenue, USD Bn, 2021 - 2033) o Oral o Parenteral/ Injectable o Transdermal o Nasal o Others • Application Insights (Revenue, USD Bn, 2021 - 2033) o Endocrine Disorders o Reproductive Health o Oncology o Growth Disorders o Others • Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033) o Hospital Pharmacies o Retail Pharmacies o Online Pharmacies • Regional Insights (Revenue, USD Bn, 2021 - 2033) o North America  U.S.  Canada o Latin America  Brazil  Argentina  Mexico  Rest of Latin America o Europe  Germany  U.K.  Spain  France  Italy  Russia  Rest of Europe o Asia Pacific  China  India  Japan  Australia  South Korea  ASEAN  Rest of Asia Pacific o Middle East  GCC Countries  Israel  Rest of Middle East o Africa  South Africa  North Africa  Central Africa • Key Players Insights o Pfizer Inc o Merck o Novartis AG o Hoffmann La Roche Ltd o Sanofi o Novo Nordisk A/S o Eli Lilly and Company o AbbVie Inc o Bayer AG o Teva Pharmaceutical Industries Ltd

目錄 Table of Contents

Table of Contents 1. Research Objectives and Assumptions o Research Objectives o Assumptions o Abbreviations 2. Market Purview o Report Description  Market Definition and Scope o Executive Summary  Global Hormonal Drugs Market, By Product Type  Global Hormonal Drugs Market, By Route of Administration  Global Hormonal Drugs Market, By Application  Global Hormonal Drugs Market, By Distribution Channel  Global Hormonal Drugs Market, By Region 3. Market Dynamics, Regulations, and Trends Analysis o Market Dynamics o Impact Analysis o Key Highlights o Regulatory Scenario o Product Launches/Approvals o PEST Analysis o PORTER’s Analysis o Market Opportunities o Regulatory Scenario o Key Developments o Industry Trends 4. Global Hormonal Drugs Market, By Product Type, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Insulin and Analogues  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Testosterone Therapies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Thyroid Hormone Therapies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Estrogen and Progesterone Therapies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Human Growth Hormone (HGH)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Corticosteroids  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Gonadotropins (FSH, LH, hCG)  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 5. Global Hormonal Drugs Market, By Route of Administration, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Oral  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Parenteral/ Injectable  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Transdermal  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Nasal  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 6. Global Hormonal Drugs Market, By Application, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Endocrine Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Reproductive Health  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Oncology  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Growth Disorders  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Others  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 7. Global Hormonal Drugs Market, By Distribution Channel, 2021-2033, (USD Bn) o Introduction  Market Share Analysis, 2026 and 2033 (%)  Y-o-Y Growth Analysis, 2022 - 2033  Segment Trends o Hospital Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Retail Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) o Online Pharmacies  Introduction  Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn) 8. Global Hormonal Drugs Market, By Region, 2021 - 2033, Value (USD Bn) o Introduction  Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)  Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)  Regional Trends o North America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o U.S. o Canada o Latin America  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Brazil o Argentina o Mexico o Rest of Latin America o Europe  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o Germany o U.K. o Spain o France o Italy o Russia o Rest of Europe o Asia Pacific  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o China o India o Japan o Australia o South Korea o ASEAN o Rest of Asia Pacific o Middle East  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn) o GCC Countries o Israel o Rest of Middle East o Africa  Introduction  Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)  Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn) o South Africa o North Africa o Central Africa 9. Competitive Landscape o Pfizer Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Merck  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Novartis AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Hoffmann La Roche Ltd  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Sanofi  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Novo Nordisk A/S  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Eli Lilly and Company  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o AbbVie Inc  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Bayer AG  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies o Teva Pharmaceutical Industries Ltd  Company Highlights  Product Portfolio  Key Developments  Financial Performance  Strategies 10. Analyst Recommendations o Wheel of Fortune o Analyst View o Coherent Opportunity Map 11. References and Research Methodology o References o Research Methodology o About us *Browse 32 market data tables and 28 figures on 'Hormonal Drugs Market' - Global forecast to 2033

提及公司

Pfizer IncMerckNovartis AGHoffmann La Roche LtdSanofiNovo Nordisk A/SEli Lilly and CompanyAbbVie IncBayer AGTeva Pharmaceutical Industries Ltd

同分類最新報告（醫療與生命科學）

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們